CytoDyn Files an IND and Full Protocol for Phase 2 Study in GvHD

Company research has produced data to expand the potential clinical indications for PRO 140 for autoimmune diseases.(PRWeb October 20, 2015)Read the full story at http://www.prweb.com/releases/2015/10/prweb13032719.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news